HLA-B Antibodies

Santa Cruz Biotechnology offers a broad range of HLA-B monoclonal antibodies for advanced research in immunology and cell biology. HLA-B monoclonal antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). HLA-B is a critical component of the major histocompatibility complex (MHC) class I molecules, playing a vital role in the immune response by presenting peptide antigens to CD8+ T cells. This function is essential for the recognition and elimination of infected or malignant cells, making HLA-B a key player in transplant compatibility and autoimmune disease research. Understanding the dynamics of HLA-B expression and function can provide insights into various pathological conditions and therapeutic strategies. HLA-B monoclonal antibodies enable researchers to explore immune system responses in different disease states. Investigating HLA-B interactions helps advance our understanding of immune surveillance and cellular recognition mechanisms. Research with HLA-B monoclonal antibodies supports the development of targeted immunotherapies and personalized medicine approaches. Santa Cruz Biotechnology monoclonal antibodies for HLA-B research continue to support scientific discoveries that advance our understanding of immune system function and disease treatment.